STAGE IIIC NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IIIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of new lung cancer drug combo completed
Disease control CompletedThis study tested the safety and side effects of a new drug, ONO-7475, when given alongside the standard drug osimertinib. It involved 78 adults with advanced or recurrent non-small cell lung cancer that has a specific genetic change (EGFR mutation). The main goal was to find a s…
Matched conditions: STAGE IIIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Ono Pharmaceutical Co. Ltd • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
MRI-Guided radiation trial aims to control tough lung cancers
Disease control CompletedThis study tested whether using MRI guidance could make radiation treatment more precise for people with inoperable, advanced non-small cell lung cancer. Twenty-six participants received a combination of targeted radiation, chemotherapy, and an immunotherapy drug called durvaluma…
Matched conditions: STAGE IIIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC